AdvanCell News and Activities

View the org chart displaying its 31 main executives

Most searched biographies at AdvanCell

• Andrew Adamovich, Chief Executive Officer
• Bill Ferris, Director
• Andrew Kay, Chairman of the Board

Popular executive movements at AdvanCell

• Simon Puttick, who was Chief Scientific Officer, is promoted to Chief Isotope Development Officer  (posted on June 10 2026).
• Francois Gaudet has joined the company as Chief Scientific Officer  (posted on June 10 2026).
• Justyna Kelly has joined the company as Chief Technology Officer  (posted on June 10 2026).

Click here to view some more movements at AdvanCell

Create your alert
to follow the executive moves at AdvanCell.

AdvanCell has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by AdvanCell

Social media about AdvanCell

• AdvanCell on Wikipedia, Google News & Yahoo Finance
• AdvanCell on LinkedIn, X (Twitter) & YouTube